PP
CLBT icon

PDT Partners’s Cellebrite CLBT Stock Holding History

PDT Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Buy
+10,400
New +$157K 0.01% 513
2025
Q3 		– Sell
-113,527
Closed -$1.82M – 603
2025
Q2 		$1.82M Sell
113,527
-92,205
-45% -$1.64M 0.1% 322
2025
Q1 		$4M Buy
205,732
+82,890
+67% +$1.74M 0.28% 104
2024
Q4 		$2.71M Buy
122,842
+97,539
+385% +$1.88M 0.24% 143
2024
Q3 		$426K Buy
+25,303
New +$375K 0.04% 536

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PDT Partners's CLBT Position: Q1 2026 in Review

PDT Partners opened a new position in Cellebrite (CLBT) in Q1 2026: 10,400 shares worth $143K. The stake represents 0.01% of the portfolio and ranks #513 among its holdings. This is a return to the name: PDT Partners previously reported a position in CLBT as recently as Q2 2025.

PDT Partners first reported a position in CLBT in Q3 2024 and has held it in 5 quarters since. The position peaked at $4M in Q1 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • PDT Partners held 10,400 shares of Cellebrite worth $143K as of Q1 2026.
  • Cellebrite was a new PDT Partners position in Q1 2026.
  • Cellebrite made up 0.01% of PDT Partners's portfolio in Q1 2026, its #513 holding.
  • PDT Partners first reported a position in Cellebrite in Q3 2024 and has held it in 5 quarters since.
  • PDT Partners's Cellebrite position peaked at $4M in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.